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 Abstract—Cell mechanics, in particular mechanical properties, 
has been suggested as a new biomarker indicative of cell state and 
phenotype. Acute myeloid leukemia (AML) is characterized by 
the abnormal increase of myeloblasts in blood and bone marrow.  
While AML has been extensively studied from the perspectives of 
biochemical and genetic aspects, little is known about its cellular 
biophysical properties. In this study, optical tweezer technology 
was used to examine the micromechanical properties of 
myeloblasts from bone marrow of AML patients at single cell 
level. The myeloblasts were separately analyzed according to their 
expression of CD34+, a marker of primitive hematopoietic cells. 
To extract the intrinsic properties from the relationship between 
the stretching force and the induced deformation, a theoretical 
approach was developed to model the mechanical responses of 
cells and further characterize their mechanical properties. The 
preliminary results show that the area compressibility modulus of 
CD34+ myeloblasts was significantly less than that of CD34- cells, 
which indicate that micromechanical properties are unique 
features of myeloblasts and provide us with an insight into the cell 
mechanics of primitive AML cells. 
I. INTRODUCTION 
Cell mechanics determines how a cell senses and responds to 
external or internal mechanical stimuli and plays an important 
role in regulating cellular functions, such as cell growth, 
migration, differentiation, division, and apoptosis [1]. Cell 
mechanics, in particular mechanical properties, is mainly 
determined by cellular cytoskeleton network. Any changes in 
cytoskeleton may lead to changes in cell mechanics and further 
result in development of numerous diseases and abnormal 
mechanotransduction [2]. Accumulating evidence has 
suggested that cell mechanical properties may be associated 
with the onset and progression with some diseases [3], [4]. For 
example, red blood cells (RBC) obtained from patients with 
sickle cell disease or infected by plasmodium falciparum 
displayed lower deformability and sticky behaviors [5], [6], 
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which led to abnormal microcirculation. Metastatic cancer cells 
were demonstrated to be more than 70% softer than their 
benign counterparts [7]. Prostate cancer cells with different 
metastatic potentials exhibited distinct Young’s moduli [8]. 
Moreover, micromechanical properties may be indication of 
cell phenotype. For instance, cardiac cells exhibited 
significantly higher viscoelastic modulus than skeletal muscle 
cells [9], [10].  
Acute myeloid leukemia (AML) is characterized by the 
abnormal increase of myeloblasts in blood and bone marrow 
[11]. Induction chemotherapy is the mainstay of treatment. 
However, mortality of AML patients is high and few can be 
cured and survive in the long term [12]. AML is considered to 
be initiated by unchecked growth of immature cells as a result 
of accumulated mutations. Recent studies suggest that 
leukemic cells are heterogenous and their biological functions 
are diverse among the population [13]-[16]. For example, AML 
CD34+ cells exhibited more resistance to apoptosis than CD34- 
fractions [13]. CD34+CD38- leukemia progenitors had 
increased chemotherapy resistance, decreased immunogenicity 
and dendritic cell transformation capacities compared to 
CD34+CD38+ cells [15]. The primitive CD34+ cells displayed 
higher sensitivity to the cholesterol synthesis inhibitor 
lovastatin than CD34- cells [16]. However, the underlying 
mechanisms are still not fully understood. Currently, study on 
diseases mainly focuses on the molecular, microbiological, 
immunological and pathological aspects. The connection 
between cell mechanics and diseases, such as AML, remains 
elusive. While AML has been characterized by morphologic, 
karyotypic and more recently genetic features [17], [18], 
information pertaining to its cellular biophysical properties is 
completely lacking. 
Optical tweezers provide the ability to apply force and 
deformation on a micro-scaled object on the order of 
picoNewton (pN, 10-12 N) and nanometer (nm, 10-9 m), 
respectively. This technology is utilized in this study to 
manipulate primitive myeloblasts from AML patients for 
biomechanical properties characterization. Cells are stretched 
by progressively increasing the distance between the beads. 
Through force calibration and image processing, the 
relationship between the stretching force and the induced cell 
deformation can be established, from which the biomechanical 
properties of CD34 cells are characterized based on our cell 
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 mechanical model [19], [20]. The findings in this study will 
provide insights into the cell mechanics of primitive AML 
hematopoietic cells.  
II. CELL MECHANICAL MODEL 
In cell stretching, micro-beads were attached to cell surfaces 
serving as handles. A cell was stretched by progressively 
increasing the distance between the beads. We assumed that the 
shape of the suspended cell before deformation was spherical. 
Because of the symmetry of both cell shape and imposed force, 
the shape of the cell after optical stretching was rotationally 
symmetric. The problem of mechanical modeling was then 
simplified to be two-dimensional, as shown in Fig. 1. 
Membrane theory has been used to describe the deformation 
behaviors during cell manipulation, such as optical stretching 
and cell injection [19]-[22]. A biological cell, especially a 
suspended cell, was usually simplified to be a pressurized 
liquid drop enveloped by a spherical biomembrane [19]-[23], 
which was represented by a thin layer of membrane. Cellular 
resistance to external forces could be described by membrane 
theory. The equilibrium equations were used to represent the 
force balance of the cell membrane, expressed as follows 
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where m  and c , mT  and cT , and mK and cK are the principal 
stretch ratios, tensions and curvatures, respectively. n  was the 
pressure normally acting on the membrane. The definitions of 
all the quantities can be found in [19]-[22].  
 
 
Fig. 1. (a) Schematic of cell stretching,  (b) Coordinate definition for biological 
cells before and after optical stretching, and (c) calculated deformed cell shapes, 
where the blue line denotes the initial spherical cell shape. 
 
The constitutive material proposed by Evans and Skalak was 
used to represent the deformation characteristics of cell 
membranes [24]. We assumed that the membrane tensions were 
uniform and isotropic, the membrane tensions mT  and cT could 
be derived as follows [24] 
m cT T k		                                    (3) 
where k	  is the area compressibility modulus. 	  is the area 
dilation ratio defined by 0 0( ) /A A A	   , where 0A  and A are 
the areas of the cell surface before and after stretching.  
Given the biomechanical property k	 , the equilibrium 
equations (1) and (2) can be solved numerically [19], [20]. The 
stretching force and the cell deformation can be then calculated 
as well as the deformed cell shapes (Fig. 1c). Thereafter, the 
deformation-force relationship is established.  
III. CELL STRETCHING EXPERIMENTS  
A. Experimental System 
Fig. 2 shows the optical tweezer system (BioRyx 200, Arryx), 
which mainly includes a multiple optical trap system, an 
inverted optical microscope (Nikon TE2000, Japan), an X-Y-Z 
motorized stage (ProScan, Prior Scientific), and a CCD system. 
A continuous wave laser beam (YLM-3-1064-LP-AX1, IPG 
Photonics) with wavelength of 1064 nm is transmitted via the 
optical fiber and sculpted by the holographic optical tweezer 
(HOT) device. Multiple optical traps are then created on the 
observation plane. Positions of optical traps can be controlled 
individually in three dimensions by the HOT device through 
modulating the phase distribution of a spatial light modulator. 
These well-controlled traps serve as micro end-effectors to 
manipulate multiple micro/nano-scaled objects with size 
ranged from 100 nm to 100 μm. The sample is contained in a 
home-built chamber, which is placed on the motorized stage 
with a positioning accuracy of 40 nm. The manipulation 
process is monitored by the CCD detection system and 
positions of the targets are obtained through image processing.  
 
Fig. 2. Robotic manipulation system with optical tweezers (HOT: holographic 
optical tweezer). 
B. Experimental Preparation 
With informed consent, myeloblasts were isolated and 
purified from the bone marrow of patients with AML. 
Microscope  
X-Y motorized 
stage  
Joystick  CCD 
Z-axis stage  
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 According to the standard procedures [25], these cells were 
fractionated in terms of CD34+ expression, a marker of 
primitive hematopoietic cells.  
Before experiments, micro-beads were attached to the cell 
surface. The detailed procedure was given elsewhere [20]. In 
brief, streptavidin-coated polystyrene beads (Bangs Lab., 
Fishers, IN) were incubated with biotinylated concanavalin A 
(ConA, Sigma) at 4?. The treated beads were then mixed with 
cell suspension to create cell-bead attachment.  
The viscous-drag-force calibration method was adopted here 
to evaluate the optical forces. When a bead was driven in a flow 
by an optical trap, the escaping force was equal to the viscous 
force calculated according to Stokes’ law [20], [26]. The 
relationship between laser power and optical force was 
established through calibration.  
C. Cell Stretching 
  
  
Fig. 3. Process of cell stretching. (a) Before stretching, (b) during stretching, (c) 
stretching to the maximum deformation, and (d) the bead escapes the trap. The 
scale bar is 5 μm.  
 
The diluted cell-bead mixture was injected into the chamber 
for stretching experiments. Fig. 3 illustrates the process of cell 
stretching. The cell with two beads bound to the opposite sides 
in diameter or with one side attached to the chamber and the 
other side bound to a bead was chosen for test. With one bead 
fixed by an optical trap, the other bead was grasped and moved 
by another trap. The moving direction was determined along 
the joint line passing the centroids of the two beads. The cell 
was stretched by progressively increasing the distance between 
the beads. When the deviation between cell and bead exceeded 
a critical value, the trapping force decreased dramatically. Then 
the bead escaped the trap, as shown in Fig. 3 (d). By adjusting 
laser power, various optical forces could be obtained from the 
calibrated force-power relationship. Note that cell deformation 
was measured from the image where the cell was stretched to 
the maximum deformation and further stretch would lead to 
bead escape from the trap, as shown in Fig. 3 (c). Therefore, the 
relationship between the stretching force and the cell 
deformation was then established. We performed several times 
of cell stretching tests on each cell. It was found in experiments 
that some cells exhibited stiffening characteristics after 
repetitive stretching (more than five times). To exclude this 
influence, the experimental data in the first three times tests 
were utilized in this paper.  
 
Fig. 4. Different deformation behaviors of CD34+ and CD34- cells from patients 
with AML. The scale bar is 5 μm. 
IV. RESULTS AND DISCUSSIONS 
We measured the mechanical stiffness of myeloblasts from 
AML patients separately in terms of CD34+ expression. The 
experiments were repeated three times, where 62~71 CD34+ 
cells and 57~63 CD34- cells were tested in total during the 
stretching experiments and the results were averaged.  
In experiments, no significant difference was found in the 
cell size of CD34+/- population, i.e., 10.1±1.0 μm and 10.6±1.4 
μm for the diameter of CD34+ and CD34- cells, respectively. 
Typical deformation responses of CD34+/- cells under different 
stretching forces are shown in Fig. 4. Increasing membrane 
stress was exerted on the cell surface as the cell was stretched. 
The deformation of AML CD34+ cells is much larger than that 
of CD34- cells, which suggests that there exists significant 
difference in the deformability of AML CD34+ and CD34- cells. 
The difference in deformability indicates that AML cells with 
different phenotypes exhibit distinct biomechanical properties.   
Fig. 5 shows the quantitative analysis of the deformation 
behaviors of AML CD34+/- cells. It can be seen that the 
deformation of CD34+ cells varies over a relatively wide range 
compared to that of CD34- cells.  This finding may suggest that 
AML CD34+ fraction may contain multiple subpopulations, 
which are heterogeneous from the perspective of cell 
mechanics, in particular, cell deformability. Nevertheless, all 
the measurement results show that the induced deformation of 
CD34+ cells is greater than CD34- cells under the same 
stretching force, indicating that the primitive CD34+ cells are 
CD34- cells 
 
 
 
 
CD34+ cells 
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(d) (c) 
F = 0 pN 
F = 20 pN
F = 0 pN 
F = 38 pN
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 significantly softer than CD34- cells, i.e., CD34+ cells exhibit 
much higher deformability. Additionally, both CD34+ and 
CD34- cells displayed two-phase deformation behavior. In the 
first phase, AML CD34+/- cells responded quasi-linearly to the 
small optical force. When the force increased to some extent, 
AML myeloblasts exhibited ‘saturated’ mechanical 
characteristics, i.e., the cell deformation entered into a plateau 
and the growth of the deformation lowered down. To evaluate 
the biomechanical properties of AML myeloblasts, the cell 
mechanical model described above was applied. The modeling 
deformation behaviors in cell stretching are also shown in Fig. 
5. Based on this model, the area compressibility modulus k, 
was characterized as 0.25±0.15 N/m and 1.40±0.71 N/m for 
CD34+ and CD34- myeloblasts, respectively. This finding 
indicates that AML CD34- cells are significantly stiffer than 
CD34+ cells, which may be related to their unique functions of 
these two AML cell populations. Recent reports have 
confirmed the presence of leukemic stem cells (LSC) in the 
population of CD34+ cells [14]. The significance of this finding 
in relation to leukemogenesis particularly at the LSC level 
would have to be further examined. 
        Force 
(pN) 
Cell type 
0 14.2 21.0 27.8 34.7 41.5 
AML CD34+ 
cells 
0 1.83 2.71 3.53 3.85 4.36 
SD (CD34+ 
cells) 
0 0.65 1.03 1.34 1.62 1.86 
AML CD34- 
cells 
0 0.32 0.51 0.86 1.10 1.33 
SD (CD34- 
cells) 
0 0.23 0.32 0.51 0.52 0.53 
SD: standard deviation. The values in the table exclusive of the first row denote 
the cell deformations under various stretching forces and the unit is μm.  
V. CONCLUSIONS 
In summary, this paper presented our latest results of 
mechanical characterization of myeloblasts from patients with 
AML. Optical tweezers were used to examine the mechanical 
properties of AML cells in terms of CD34+ expression. A cell 
mechanical model was developed to interpret the deformation 
behaviors of cells, from which the area compressibility 
modulus of cells was characterized. The results showed that 
CD34+ cells exhibited higher deformability than CD34- cells. 
The connection between this finding and leukemogenesis needs 
to be further investigated in future.  
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